- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Study maps how NF-κB regulates gene expression in cells
Researchers gain unprecedented insight into the intricate mechanisms governing gene expression, potentially paving the way for revolutionary therapies.
Published on Feb. 28, 2026
Got story updates? Submit your updates here. ›
Researchers have developed a novel method, fluctuation spectroscopy, to observe the dynamic behavior of a protein called Dorsal, a variant of nuclear factor-κB (NF-κB), and its role in cellular decision-making. The study, published in Science Advances, reveals a surprising non-linear relationship between the amount of NF-κB freely moving around within the cell and the amount bound to DNA, providing a more nuanced understanding of the process and suggesting that therapies may need to focus on precisely controlling where and how NF-κB binds to DNA.
Why it matters
NF-κB is a critical transcription factor that influences a wide range of cellular behaviors, including inflammation, innate immunity, and wound healing. Understanding how NF-κB functions, and malfunctions, is key to tackling numerous diseases such as cancer. This research could lead to the ability to control these cellular processes and develop targeted therapies.
The details
The researchers have developed a novel method, fluctuation spectroscopy, to observe the dynamic behavior of Dorsal within the cell nucleus. This technique allows them to distinguish between Dorsal molecules that are moving quickly, slowly, or not at all, and create a comprehensive 'map' illustrating the relationship between the amount of Dorsal present in the nucleus and how much of it is actively bound to DNA. The research reveals a surprising finding: the amount of NF-κB freely moving around within the cell remains constant across different parts of the embryo, whereas the amount bound to DNA varies, indicating a non-linear relationship between the two.
- The study was published on February 28, 2026.
The players
Dr. Gregory Reeves
A researcher at Texas A&M University who led the study.
What they’re saying
“This level of understanding could lead to the ability to control these cellular processes ourselves, because mistakes in NF-κB activity can lead to disease states, such as cancer.”
— Dr. Gregory Reeves, Researcher, Texas A&M University (Science Advances)
“With this knowledge of how Dorsal is interacting with the DNA, we have a better understanding of how much we would need to activate the NF-κB pathway, if we needed to intervene for therapeutic purposes.”
— Dr. Gregory Reeves, Researcher, Texas A&M University (Science Advances)
What’s next
The researchers plan to continue their work on developing mathematical models to predict the effects of different interventions targeting the NF-κB pathway, with the goal of informing the development of more precise and effective therapies.
The takeaway
This research represents a significant step forward in our understanding of how transcription factors like NF-κB regulate gene expression, which could lead to the development of new targeted therapies for a wide range of diseases, from cancer to autoimmune disorders.
